Kyung Nam PharmLtd Dividends and Buybacks
Dividend criteria checks 0/6
Kyung Nam PharmLtd does not have a record of paying a dividend.
Key information
n/a
Dividend yield
4.3%
Buyback Yield
| Total Shareholder Yield | 4.3% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) After Shares Rise 29%
Nov 11
Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950) Stock Rockets 37% As Investors Are Less Pessimistic Than Expected
Aug 19Subdued Growth No Barrier To Kyung Nam Pharm Co.,Ltd.'s (KOSDAQ:053950) Price
May 21Does Kyung Nam PharmLtd (KOSDAQ:053950) Have A Healthy Balance Sheet?
Mar 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A053950's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A053950's dividend payments have been increasing.
Dividend Yield vs Market
| Kyung Nam PharmLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A053950) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A053950) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A053950's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A053950's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A053950's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A053950 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:58 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kyung Nam Pharm Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Young Ok Kim | DAOL Investment & Securities Co., Ltd. |
| Joon-Geun Choi | Shinhan Investment Corp. |
| Kang Ho Oh | Shinhan Investment Corp. |